Am. J. Respir. Cell Mol. Biol., Volume 22, Number 6, June, 2000 708-713

Expression of Interleukin-18 in the Lung after Endotoxemia or Hemorrhage-Induced Acute Lung Injury

Patrick G. Arndt, Giamilla Fantuzzi, and Edward Abraham

Divisions of Pulmonary and Critical Care Medicine, and Infectious Diseases, University of Colorado Health Sciences Center, Denver, Colorado

Hemorrhage and endotoxemia are important risk factors for the development of acute lung injury. Interleukin (IL)-18 is a recently described cytokine released in its mature, active form after pro-IL-18 is cleaved by the IL-1 converting enzyme (ICE). IL-18 has multiple immunomodulating properties, including induction of interferon- (IFN-), IL-1, tumor necrosis factor-, and intercellular adhesion molecule-1. To examine the possible involvement of IL-18 in acute lung injury, we examined its expression, as well as that of IFN-, IL-12, and ICE, using murine hemorrhage or endotoxemia models. The amounts of IL-18 messenger RNA (mRNA) increased in the lung after hemorrhage or endotoxemia. However, only endotoxemia was associated with elevations in lung and plasma concentrations of IL-18 protein. ICE expression was increased in the lungs after endotoxemia but not after hemorrhage. Although IFN- expression increased in the lungs after hemorrhage or endotoxemia, elevations in lung IL-12 mRNA levels were found only after endotoxemia. These results indicate that hemorrhage and endotoxemia induce different patterns of immunomodulatory cytokine expression in the lungs. In particular, differences in the expression of ICE after hemorrhage or endotoxemia may affect generation of the active forms of downstream cytokines, including IL-18. IFN- expression in the lungs after hemorrhage appears to occur through a pathway independent of IL-12 and IL-18. IL-18 may play a role in modulating the development of acute lung injury after endotoxemia but not after hemorrhage.

This article has been cited by other articles:

				E. Abraham Computational Design of Variant TNF Molecules: A Novel Methodology for Inhibition of Proinflammatory Cascades Sci. Signal., November 11, 2003; 2003(208): pe51 - pe51. [Abstract] [Full Text] [PDF]

				S. Weijer, M. E. Sewnath, A. F. de Vos, S. Florquin, K. van der Sluis, D. J. Gouma, K. Takeda, S. Akira, and T. van der Poll Interleukin-18 Facilitates the Early Antimicrobial Host Response to Escherichia coli Peritonitis Infect. Immun., October 1, 2003; 71(10): 5488 - 5497. [Abstract] [Full Text] [PDF]

				M. J. Schultz, S. Knapp, S. Florquin, J. Pater, K. Takeda, S. Akira, and T. van der Poll Interleukin-18 Impairs the Pulmonary Host Response to Pseudomonas aeruginosa Infect. Immun., April 1, 2003; 71(4): 1630 - 1634. [Abstract] [Full Text]

				T. H. Wyman, C. A. Dinarello, A. Banerjee, F. Gamboni-Robertson, A. A. Hiester, K. M. England, M. Kelher, and C. C. Silliman Physiological levels of interleukin-18 stimulate multiple neutrophil functions through p38 MAP kinase activation J. Leukoc. Biol., August 1, 2002; 72(2): 401 - 409. [Abstract] [Full Text] [PDF]

				C. D. Raeburn, C. A. Dinarello, M. A. Zimmerman, C. M. Calkins, B. J. Pomerantz, R. C. McIntyre Jr., A. H. Harken, and X. Meng Neutralization of IL-18 attenuates lipopolysaccharide-induced myocardial dysfunction Am J Physiol Heart Circ Physiol, August 1, 2002; 283(2): H650 - H657. [Abstract] [Full Text] [PDF]

				J.D. Aitchison, H.E. Orr, P.A. Flecknell, J.A. Kirby, and J.H. Dark Functional assessment of non-heart-beating donor lungs: prediction of post-transplant function Eur. J. Cardiothorac. Surg., July 1, 2001; 20(1): 187 - 194. [Abstract] [Full Text] [PDF]